Evidence map›Paper›PMID 34490633›Full record

ArticleHealth services research2021

International comparison of spending and utilization at the end of life for hip fracture patients.

Carl Rudolf Blankart, Kees van Gool, Irene Papanicolas, Enrique Bernal-Delgado, Nicholas Bowden, Francisco Estupiñán-Romero, Robin Gauld, Hannah Knight, Olukorede Abiona, Kristen Riley and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Health services research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Applying the hospital administrative data quality scoring tool in 15 countries.Health information management : journal of the Health Information Management Association of Australia · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 7 countries.

Carl Rudolf BlankartKPM Center for Public Management, University of Bern, Bern, Switzerland.ORCID 0000-0001-6719-0038
Kees van GoolCentre for Health Economics Research and Evaluation (CHERE), University of Technology, Sydney, Australia.ORCID 0000-0002-1424-9304
Irene PapanicolasDepartment of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-8000-3185
Enrique Bernal-DelgadoInstitute for Health Sciences in Aragon (IACS), Zaragoza, Aragon, Spain.ORCID 0000-0002-0961-3298
Nicholas BowdenDepartment of Women's and Children's Health, University of Otago, Dunedin, New Zealand.ORCID 0000-0003-4589-9956
Francisco Estupiñán-RomeroInstitute for Health Sciences in Aragon (IACS), Zaragoza, Aragon, Spain.ORCID 0000-0002-6285-8120
Robin GauldOtago Business School and Centre for Health Systems and Technology, University of Otago, Dunedin, New Zealand.ORCID 0000-0001-5401-1192
Hannah KnightThe Health Foundation, London, UK.ORCID 0000-0002-6809-2517
Olukorede AbionaCentre for Health Economics Research and Evaluation (CHERE), University of Technology, Sydney, Australia.ORCID 0000-0002-1696-4475
Kristen RileyDepartment of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-1322-050X
Andrew J SchoenfeldDivision of Orthopedic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-3691-1215
Kosta ShatrovKPM Center for Public Management, University of Bern, Bern, Switzerland.ORCID 0000-0002-6421-6754
Walter P WodchisInstitute of Health Policy Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-2494-7031
Jose F FigueroaDepartment of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0003-3811-257X
ICCONIC Collaboration
Harvard University · USUniversity of Bern · CHUniversity of Otago · NZUniversity of Technology Sydney · AUBrigham and Women's Hospital · USHealth Foundation · GBUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify and explore differences in spending and utilization of key health services at the end of life among hip fracture patients across seven developed countries. DATA SOURCES: Individual-level claims data from the inpatient and outpatient health care sectors compiled by the International Collaborative on Costs, Outcomes, and Needs in Care (ICCONIC). STUDY

designWe retrospectively analyzed utilization and spending from acute hospital care, emergency department, outpatient primary care and specialty physician visits, and outpatient drugs. Patterns of spending and utilization were compared in the last 30, 90, and 180 days across Australia, Canada, England, Germany, New Zealand, Spain, and the United States. We employed linear regression models to measure age- and sex-specific effects within and across countries. In addition, we analyzed hospital-centricity, that is, the days spent in hospital and site of death. DATA COLLECTION/EXTRACTION

methodsWe identified patients who sustained a hip fracture in 2016 and died within 12 months from date of admission. PRINCIPAL

findingsResource use, costs, and the proportion of deaths in hospital showed large variability being high in England and Spain, while low in New Zealand. Days in hospital significantly decreased with increasing age in Canada, Germany, Spain, and the United States. Hospital spending near date of death was significantly lower for women in Canada, Germany, and the United States. The age gradient and the sex effect were less pronounced in utilization and spending of emergency care, outpatient care, and drugs.

conclusionsAcross seven countries, we find important variations in end-of-life care for patients who sustained a hip fracture, with some differences explained by sex and age. Our work sheds important insights that may help ongoing health policy discussions on equity, efficiency, and reimbursement in health care systems.

Indexed as

Cross-Cultural ComparisonHip FracturesAgedAged, 80 and overAustraliaDeveloped CountriesEuropeFemaleHealth Care CostsHospitalizationHumansInsurance Claim ReviewLongitudinal StudiesMaleNorth AmericaPatient Acceptance of Health Careadministrative dataage inequalitiesend-of-life caregender inequalitieshealth care spendinghealth care utilizationinternational comparison

Identifiers

PMID34490633
PMCPMC8579204
OpenAlexW3197254846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.